Reduction of Bedrest Time of Post Percutaneous Renal Biopsy Patients (RUBBY)

Hospital de Clinicas de Porto Alegre

Status: Unknown

Conditions: Bedrest

Treatments: Other: wonder around; Behavioral: bedrest

Study type: Interventional

Funder types: Other

Identifiers

NCT04629235

170430

Details and patient eligibility

About

To compare the reduction of the bedrest time of the patient after percutaneous renal biopsy from 24 hours to 8 hours in relation to the occurrence of complications evaluated by the Nursing Outcome Classification (NOC) indicators.

Full description

Percutaneous renal biopsy (BRP) is an important procedure for the diagnosis, prognostic evaluation and therapeutic orientation of several kidney diseases. Although it is considered a safe procedure, BRP complications can occur and, most of the time, are related to the risk of bleeding and the main consequence of BRP. Complications include macroscopic hematuria and hematoma requiring blood transfusion, surgical intervention, or invasive procedure. Since hemorrhagic complications continue to be the highest risk after BRP due to severity and potential life-threatening risk, there is an effort to minimize the risk of bleeding by checking blood clotting markers prior to the procedure, uncontrolled hypertension and the use of antiplatelet drugs and anticoagulants. The relevance of this study is to seek better evidence for clinical practice, considering the lack of Brazilian studies on the subject and the positive impact on patient comfort, besides the reduction of costs for the institution and overload in the work of the multidisciplinary team. In addition, it will contribute to the strengthening of the use of NOC in clinical practice and to the improvement of nursing knowledge.

Enrollment: 140 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All patients undergoing renal biopsy at Hospital de Clínicas de Porto Alegre (HCPA);
• Both sexes;
• Aged 18 years or older.

Exclusion criteria

• Patients with the following risk factors for complications;
• More than two punctures during the procedure;
• Larger gauge needle;
• Uncontrolled blood pressure;
• Blood clotting disorders and use of antiplatelet agents (aspirin or clopidogrel), or use of anticoagulants;
• Bedridden patients and patients unable to adequately to ambulate.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

140 participants in 2 patient groups

24 hours of bedrest

Active Comparator group

Description:

- 24 hours of bedrest

Treatment:

Behavioral: bedrest

Intervention group

Experimental group

Description:

- Wonder around after 8 hours of bedrest

Treatment:

Other: wonder around